IMARC Group’s report titled “Surrogacy Market Report by Type (Gestational Surrogacy, Traditional Surrogacy), Technology (IVF with ICSI, IVF without ICSI, Intrauterine Insemination), Service Provider (Hospitals, Fertility Clinics, and Others), and Region 2024-2032“, Offers a comprehensive analysis of the industry, which comprises insights on the market share. The global surrogacy market size reached US$ 183.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 306.9 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.

Factors Affecting the Growth of the Global Surrogacy Industry:

  • Increasing Social Acceptance:

The increasing social acceptance and awareness of surrogacy as a means to achieve parenthood are also driving the global surrogacy market. Changing societal attitudes towards family structures, along with greater visibility of LGBTQ+ families and individuals facing infertility challenges, have contributed to a broader acceptance of surrogacy. Social media, along with other forms of digital communication, have played a crucial role in increasing awareness and understanding of surrogacy as a legitimate and compassionate option for family building. As the stigma associated with surrogacy diminishes, more individuals and couples are exploring this option, leading to an increase in demand for surrogacy services worldwide.

  • Rising Legalization:

One of the primary factors driving the global surrogacy market is the diversity in legal and regulatory frameworks across different countries. Some regions offer more favorable legal conditions for surrogacy, including clear parental rights, simplified citizenship processes for the child, and supportive legal environments for both surrogate mothers and intended parents. This legal clarity and support attract couples from countries with restrictive laws to seek surrogacy services abroad. Countries like Canada, parts of the USA, and Ukraine are known for their comprehensive legal frameworks that protect all parties involved in the surrogacy process. Such legal environments provide a strong foundation for the growth of surrogacy agencies, fertility clinics, and legal services, contributing significantly to the market's expansion.

  • Technological Advancements:

Advancements in reproductive technologies, particularly in vitro fertilization (IVF), have significantly contributed to the growth of the global surrogacy market. These technologies have improved success rates of pregnancy and birth, making surrogacy a viable option for individuals and couples facing infertility issues. The continuous research and development in this field have also made these technologies more accessible and affordable. As a result, a larger number of people can consider surrogacy as a realistic option for family building. Moreover, the integration of genetic screening technologies allows for the selection of healthy embryos, increasing the chances of a successful pregnancy and reducing the risk of genetic disorders, further boosting the surrogacy market's growth.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/surrogacy-market/requestsample

Leading Companies Operating in the Global Surrogacy Industry:

  • Bourn Hall Clinic
  • CARE Fertility
  • Circle Surrogacy & Egg Donation
  • Extraordinary Conceptions
  • Growing Generations LLC
  • Houston Fertility Center
  • IVIRMA Global
  • Max Healthcare
  • New Hope Fertility Center
  • Nova IVF
  • Ovation Fertility
  • Scanfert Clinic

Surrogacy Market Report Segmentation:

By Type: 

  • Gestational Surrogacy
  • Traditional Surrogacy

Gestational surrogacy dominates the market as it involves the use of the intended parents' genetic material, eliminating legal issues related to genetic parentage.

By Technology:

  • IVF with ICSI
  • IVF without ICSI
  • Intrauterine Insemination

IVF with ICSI accounted for the largest market share as it involves the direct injection of a single sperm into an egg, which is beneficial in cases of male infertility.

By Service Provider:

  • Hospitals
  • Fertility Clinics
  • Others

Fertility clinics accounted for the largest market share as they are specialized in various assisted reproductive technologies.

By Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America leads the market due to its favorable legal, medical, and social landscape, various technological advancements, and rising disposable incomes.

Key Highlights of the Report:

  • Market Performance (2018-2023)

  • Market Outlook (2024-2032)

  • Porter’s Five Forces Analysis

  • Market Drivers and Success Factors

  • SWOT Analysis

  • Value Chain

  • Comprehensive Mapping of the Competitive Landscape

Surrogacy Market Trends:

Many countries and states have witnessed a growing acceptance of surrogacy as a legitimate family-building option. Legal frameworks have evolved to provide clarity and protection for intended parents, surrogates, and children born through surrogacy arrangements.

Besides, gestational surrogacy, where the surrogate carries a child biologically unrelated to her, has become increasingly common due to advances in reproductive technology. This type of surrogacy allows for a genetic link between one or both intended parents and the child, addressing infertility challenges.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163